Literature DB >> 10539859

Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis.

M Leinonen1, P Saikku.   

Abstract

BACKGROUND: Seroepidemiologic studies have provided information on the interaction of Chlamydia pneumoniae with other known risk factors of coronary heart disease. C pneumoniae infection appears to be more common in smokers than in nonsmokers, suggesting that smoking predisposes to the development of chronic C pneumoniae infection. METHODS AND
RESULTS: In identical twins, C pneumoniae-specific immunoglobulin A levels were found to be higher and cell-mediated immunity, measured as a lymphoproliferation response, lower in smoking twins than in their nonsmoking counterparts, suggesting that chronic C pneumoniae infections are common in smokers whose cell-mediated protective immunity appears to be lowered. Infections also may have an effect on lipid metabolism. Thus even in acute pneumonia caused by C pneumoniae, high-density lipoprotein (HDL) values are lower and triglyceride values higher than in pneumonia caused by viruses and other bacteria. Furthermore, chronic C pneumoniae infection has been associated with elevated triglyceride and lowered HDL levels in otherwise healthy Finnish men. We also have explored the combined effect of chronic C pneumoniae infection and markers of the metabolic syndrome (elevated body mass index, blood glucose and systolic blood pressure, and lowered HDL cholesterol) on the risk of cardiac events. The results suggest that chronic C pneumoniae infection enhances the effect of the metabolic syndrome on the risk of coronary heart disease.
CONCLUSIONS: The known risk factors of coronary heart disease may be explained partly by their interaction with chronic C pneumoniae infection. Further studies are needed to elucidate the pathogenetic mechanisms underlying these interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10539859     DOI: 10.1016/s0002-8703(99)70286-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  High rate of seropositivity of Chlamydia pneumoniae IgA in male patients with nonalcoholic steatohepatitis.

Authors:  Fusun F Bolukbas; Cengiz Bolukbas; Fadile Zeyrek; Mehmet Aslan; Halil I Bahcecioglu; Ilyas Ozardali
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

2.  Involvement of nicotinic acetylcholine receptors in controlling Chlamydia pneumoniae growth in epithelial HEp-2 cells.

Authors:  Hiroyuki Yamaguchi; Herman Friedman; Yoshimasa Yamamoto
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

3.  A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases.

Authors:  Zhi Song; Paul Brassard; James M Brophy
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

4.  The association between past Chlamydia pneumoniae infection and markers of chronic inflammation in obese women.

Authors:  M Koziołek; B Krzyzanowska-Swiniarska; I Maczyńska; T Miazgowski; S Giedrys-Kalemba
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-16       Impact factor: 3.267

Review 5.  Infections at the nexus of metabolic-associated fatty liver disease.

Authors:  Robim M Rodrigues; Tamara Vanhaecke; Joost Boeckmans; Matthias Rombaut; Thomas Demuyser; Baptist Declerck; Denis Piérard; Vera Rogiers; Joery De Kock; Luc Waumans; Koen Magerman; Reinoud Cartuyvels; Jean-Luc Rummens
Journal:  Arch Toxicol       Date:  2021-05-24       Impact factor: 5.153

Review 6.  PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings.

Authors:  Samuel Yang; Richard E Rothman
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.